Clinical trial

Anti-obesity Pharmacotherapy and Inflammation

NCT05756764

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2023-06-01

PhaseN/A

Study timeline

Study start (actual)2023-06-01Date precision: day

Registry last updated2025-09-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Obesityunresolved

Interventions

SemaglutideDRUG · verified · RxNorm: semaglutide

Phentermine-Topiramate combinationDRUG

PhentermineDRUG · verified · RxNorm: phentermine

TirzepatideDRUG · verified · RxNorm: tirzepatide

TopiramateDRUG · verified · RxNorm: topiramate

DiethylpropionDRUG · verified · RxNorm: diethylpropion

Naltrexone/BupropionDRUG

LiraglutideDRUG · verified · RxNorm: liraglutide

Sponsors & collaborators

Louisiana State University Health Sciences Center in New Orleanslead sponsor

Tulane Universitycollaborator

Pennington Biomedical Research Centercollaborator

Ochsner Health Systemcollaborator

Mapped research locations

New OrleansLouisiana, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05756764 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.